645 related articles for article (PubMed ID: 24847020)
1. The bicomponent pore-forming leucocidins of Staphylococcus aureus.
Alonzo F; Torres VJ
Microbiol Mol Biol Rev; 2014 Jun; 78(2):199-230. PubMed ID: 24847020
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.
Seilie ES; Bubeck Wardenburg J
Semin Cell Dev Biol; 2017 Dec; 72():101-116. PubMed ID: 28445785
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus Coordinates Leukocidin Expression and Pathogenesis by Sensing Metabolic Fluxes via RpiRc.
Balasubramanian D; Ohneck EA; Chapman J; Weiss A; Kim MK; Reyes-Robles T; Zhong J; Shaw LN; Lun DS; Ueberheide B; Shopsin B; Torres VJ
mBio; 2016 Jun; 7(3):. PubMed ID: 27329753
[TBL] [Abstract][Full Text] [Related]
4. Panton-Valentine leucocidin and staphylococcal disease.
Day NP
Lancet Infect Dis; 2013 Jan; 13(1):5-6. PubMed ID: 23103174
[No Abstract] [Full Text] [Related]
5. Panton-Valentine leucocidin and pneumonia.
Diep BA; Gillet Y; Etienne J; Lina G; Vandenesch F
Lancet Infect Dis; 2013 Jul; 13(7):566. PubMed ID: 23809217
[No Abstract] [Full Text] [Related]
6. Identification of a crucial residue required for Staphylococcus aureus LukAB cytotoxicity and receptor recognition.
DuMont AL; Yoong P; Liu X; Day CJ; Chumbler NM; James DB; Alonzo F; Bode NJ; Lacy DB; Jennings MP; Torres VJ
Infect Immun; 2014 Mar; 82(3):1268-76. PubMed ID: 24379286
[TBL] [Abstract][Full Text] [Related]
7. Infection of Primary Human Alveolar Macrophages Alters Staphylococcus aureus Toxin Production and Activity.
Brann KR; Fullerton MS; Onyilagha FI; Prince AA; Kurten RC; Rom JS; Blevins JS; Smeltzer MS; Voth DE
Infect Immun; 2019 Jul; 87(7):. PubMed ID: 31010814
[TBL] [Abstract][Full Text] [Related]
8. SarS Is a Repressor of Staphylococcus aureus Bicomponent Pore-Forming Leukocidins.
Anderson EE; Dyzenhaus S; Ilmain JK; Sullivan MJ; van Bakel H; Torres VJ
Infect Immun; 2023 Apr; 91(4):e0053222. PubMed ID: 36939325
[TBL] [Abstract][Full Text] [Related]
9. Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis.
Reyes-Robles T; Lubkin A; Alonzo F; Lacy DB; Torres VJ
EMBO Rep; 2016 Mar; 17(3):428-40. PubMed ID: 26882549
[TBL] [Abstract][Full Text] [Related]
10. Counter inhibition between leukotoxins attenuates Staphylococcus aureus virulence.
Yoong P; Torres VJ
Nat Commun; 2015 Sep; 6():8125. PubMed ID: 26330208
[TBL] [Abstract][Full Text] [Related]
11. Human Monocyte-Derived Osteoclasts Are Targeted by Staphylococcal Pore-Forming Toxins and Superantigens.
Flammier S; Rasigade JP; Badiou C; Henry T; Vandenesch F; Laurent F; Trouillet-Assant S
PLoS One; 2016; 11(3):e0150693. PubMed ID: 26934588
[TBL] [Abstract][Full Text] [Related]
12. The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors.
Spaan AN; Henry T; van Rooijen WJM; Perret M; Badiou C; Aerts PC; Kemmink J; de Haas CJC; van Kessel KPM; Vandenesch F; Lina G; van Strijp JAG
Cell Host Microbe; 2013 May; 13(5):584-594. PubMed ID: 23684309
[TBL] [Abstract][Full Text] [Related]
13. Structure and Function of the Two-Component Cytotoxins of Staphylococcus aureus - Learnings for Designing Novel Therapeutics.
Badarau A; Trstenjak N; Nagy E
Adv Exp Med Biol; 2017; 966():15-35. PubMed ID: 28455832
[TBL] [Abstract][Full Text] [Related]
14. Re: is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?
Kernodle DS
J Infect Dis; 2007 Jun; 195(11):1726; author reply 1727-8. PubMed ID: 17471445
[No Abstract] [Full Text] [Related]
15. Infection with Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus t034.
Welinder-Olsson C; Florén-Johansson K; Larsson L; Oberg S; Karlsson L; Ahrén C
Emerg Infect Dis; 2008 Aug; 14(8):1271-2. PubMed ID: 18680653
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of the presence of Panton-Valentine leukocidin and clonal relationship of community- and hospital-acquired clinical isolates of Staphylococcus aureus].
Duman Y; Tekeroğlu MS; Otlu B
Mikrobiyol Bul; 2013 Jul; 47(3):389-400. PubMed ID: 23971918
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of genes encoding leukocidins in Staphylococcus aureus strains resistant and sensitive to methicillin isolated from burn patients in Taleghani Hospital, Ahvaz, Iran.
Khosravi AD; Hoveizavi H; Farshadzadeh Z
Burns; 2012 Mar; 38(2):247-51. PubMed ID: 21924558
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcus aureus toxin LukSF dissociates from its membrane receptor target to enable renewed ligand sequestration.
Haapasalo K; Wollman AJM; de Haas CJC; van Kessel KPM; van Strijp JAG; Leake MC
FASEB J; 2019 Mar; 33(3):3807-3824. PubMed ID: 30509126
[TBL] [Abstract][Full Text] [Related]
19. Identification of LukPQ, a novel, equid-adapted leukocidin of Staphylococcus aureus.
Koop G; Vrieling M; Storisteanu DM; Lok LS; Monie T; van Wigcheren G; Raisen C; Ba X; Gleadall N; Hadjirin N; Timmerman AJ; Wagenaar JA; Klunder HM; Fitzgerald JR; Zadoks R; Paterson GK; Torres C; Waller AS; Loeffler A; Loncaric I; Hoet AE; Bergström K; De Martino L; Pomba C; de Lencastre H; Ben Slama K; Gharsa H; Richardson EJ; Chilvers ER; de Haas C; van Kessel K; van Strijp JA; Harrison EM; Holmes MA
Sci Rep; 2017 Jan; 7():40660. PubMed ID: 28106142
[TBL] [Abstract][Full Text] [Related]
20. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes.
Kaneko J; Kamio Y
Biosci Biotechnol Biochem; 2004 May; 68(5):981-1003. PubMed ID: 15170101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
